Flagship Pioneering related stories
All articles and analysis
peHUB Wire: Tuesday, June 29, 2010Random Ramblings
- 5 questions with Noubar Afeyan
Noubar Afeyan of Flagship Ventures talks about the honor recently bestowed on portfolio company LS9
- Gilead Buying CGI Pharma for $120 Million
Gilead Sciences Inc. (Nasdaq: GILD) has agreed to acquire CGI Pharmaceuticals Inc., a Branford, Conn.-based drug developer focused on small molecule chemistry and kinase biology. The deal is valued at $120 million, the majority of which is an up-front cash payment.
- Mr. Afeyan Goes to Washington
Noubar Afeyan, managing partner and CEO of Flagship Ventures, was in Washington D.C. yesterday, to pick up an honor on behalf of portfolio company LS9. It's called the Presidential Green Chemistry Challenge Award, and LS9 won the "small business" category for its technology to produce hydrocarbon-based biofuels and chemicals. I spent a few minutes on the phone with Afeyan, just after the ceremony wrapped up: peHUB: What, from a business prespective, did this award mean to LS9? Afeyan: Well, the award is recognizing substanstial innovation in making a greener version of chemicals and fuels. From a business standpoint, that's precisely what LS9 has enabled -- allowing our partners to use sugar as the starting raw materials for fuels rather than petroleum.
- Netuitive Raises $10 Million
Netuitive Inc., a Reston, Va.-based provider of real-time analysis software for business service management, has raised $10 million in new VC funding. Rembrandt Venture Partners was joined by return backer MK Capital. The company previously raised over $27 million from MK, Cross Creek Capital, Bessemer Venture Partners, Columbia Capital, Flagship Ventures, Noro-Moseley Partner and Thomas Weisel Venture Partners.
- peHUB Wire: Tuesday, June 15, 2010
Tuesday Talkback
- peHUB Wire: Tuesday, June 15, 2010
Tuesday Talkback
- VC fund briefs, week of June 7, 2010
News briefs about venture firms Edgestone, Bridgescale and others
- peHUB Wire: Wednesday, June 2, 2010
Random Ramblings